Literature DB >> 4504460

Inactivation of calcitonin by specific organs.

F R Singer, J F Habener, E Greene, P Godin, J T Potts.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4504460     DOI： 10.1038/newbio237269a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN： 0090-0028


× No keyword cloud information.
  5 in total

1.  Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).

Authors:  P J Sinko; Y H Lee; V Makhey; G D Leesman; J P Sutyak; H Yu; B Perry; C L Smith; P Hu; E J Wagner; L M Falzone; L T McWhorter; J P Gilligan; W Stern
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

2.  Calcitonin secretion in renal disease.

Authors:  J C Lee; J G Parthemore; L J Deftos
Journal:  Calcif Tissue Res       Date:  1977-05

3.  Regulation of melanocyte stimulating hormone action at the receptor level: discontinuous binding of hormone to synchronized mouse melanoma cells during the cell cycle.

Authors:  J M Varga; A Dipasquale; J Pawelek; J S McGuire; A B Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

4.  Suppressive effects of 24,25-dihydroxycholecalciferol on bone resorption induced by acute bilateral nephrectomy in rats.

Authors:  J H Pavlovitch; G Cournot-Witmer; A Bourdeau; S Balsan; J A Fischer; G Heynen
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

5.  Plasma calcitonin in rats with renal failure.

Authors:  T Onishi; L J Deftos
Journal:  Calcif Tissue Int       Date:  1988-03       Impact factor: 4.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.